Regeneron Pharmaceuticals (RGO.MU) Q2 2026 Earnings

29AprConfirmed
Q1 2026
Q2 2026
7.63
8.31
8.98
9.65

Details

Expected EPS
7.632596491320001
Actual EPS
8.1089716
Surprise EPS
0.48
Surprise Percent
+6.24%

Description

Regeneron Pharmaceuticals (RGO.MU) has reported earnings of 8.1089716 per share for Q2 2026.

0 Comments

Share your thoughts